Literature DB >> 23635730

Complications and continuation of intrauterine device use among commercially insured teenagers.

Abbey B Berenson1, Alai Tan, Jacqueline M Hirth, Gregg S Wilkinson.   

Abstract

OBJECTIVE: Many U.S. health care providers remain reluctant to prescribe intrauterine devices (IUDs) to teenagers as a result of concerns about serious complications. This study examined whether 15-19-year-old IUD users were more likely to experience complications, failure, or early discontinuation than adult users aged 20-24 years and 25-44 years and whether there were differences in these outcomes between users of levonorgestrel-releasing intrauterine systems and copper IUDs.
METHODS: A retrospective cohort study was conducted using health insurance claims obtained from a private insurance company of 90,489 women who had an IUD inserted between 2002 and 2009. Logistic regression models were used to estimate the odds of experiencing complications, method failure, or early discontinuation within 12 months of insertion by age group and type of IUD inserted.
RESULTS: Serious complications, including ectopic pregnancy and pelvic inflammatory disease, occurred in less than 1% of patients regardless of age or IUD type. Women aged 15-19 years were more likely than those aged 25-44 years to have a claim for dysmenorrhea (odds ratio [OR] 1.4, confidence interval [CI] 1.1-1.6), amenorrhea (OR 1.3, CI 1.1-1.5), or normal pregnancy (OR 1.4, CI 1.1-1.8). Overall, early discontinuation did not differ between teenagers and women aged 25-44 years (13% compared with 11%, P>.05). However, use of the levonorgestrel-releasing intrauterine system was associated with fewer complications and less early discontinuation than the copper IUD in all age groups.
CONCLUSIONS: The IUD is as appropriate for teenagers to use as it is for older women, with serious complications occurring infrequently in all groups. The levonorgestrel-releasing intrauterine system may be a better choice than the copper IUD as a result of lower odds of complications, discontinuation, and failure. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23635730      PMCID: PMC4028832          DOI: 10.1097/AOG.0b013e31828b63a0

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  10 in total

Review 1.  The safety of intrauterine devices among young women: a systematic review.

Authors:  Tara C Jatlaoui; Halley E M Riley; Kathryn M Curtis
Journal:  Contraception       Date:  2016-10-19       Impact factor: 3.375

2.  Intrauterine devices at six months: does patient age matter? Results from an urban family medicine federally qualified health center (FQHC) network.

Authors:  Anita Ravi; Linda Prine; Eve Waltermaurer; Natasha Miller; Susan E Rubin
Journal:  J Am Board Fam Med       Date:  2014 Nov-Dec       Impact factor: 2.657

3.  Complications and continuation rates associated with 2 types of long-acting contraception.

Authors:  Abbey B Berenson; Alai Tan; Jacqueline M Hirth
Journal:  Am J Obstet Gynecol       Date:  2014-12-30       Impact factor: 8.661

4.  Incidence of occult leiomyosarcoma in presumed morcellation cases: a database study.

Authors:  Ana M Rodriguez; Mehmet R Asoglu; Muhammet Erdal Sak; Alai Tan; Mostafa A Borahay; Gokhan S Kilic
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2015-11-28       Impact factor: 2.831

5.  Use of frameless intrauterine devices and systems in young nulliparous and adolescent women: results of a multicenter study.

Authors:  Dirk Wildemeersch; Sohela Jandi; Ansgar Pett; Kilian Nolte; Thomas Hasskamp; Marc Vrijens
Journal:  Int J Womens Health       Date:  2014-08-06

6.  Intrauterine contraception in nulliparous women: a prospective survey.

Authors:  Alexandra M Hall; Beth A Kutler
Journal:  J Fam Plann Reprod Health Care       Date:  2015-04-08

7.  Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion.

Authors:  Brandon Howard; ElizaBeth Grubb; Maureen J Lage; Boxiong Tang
Journal:  Reprod Health       Date:  2017-06-08       Impact factor: 3.223

8.  Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review.

Authors:  Jessica N Sanders; David K Turok; Lori M Gawron; Amy Law; Lonnie Wen; Richard Lynen
Journal:  Am J Obstet Gynecol       Date:  2017-02-08       Impact factor: 8.661

Review 9.  Femilis(®) 60 Levonorgestrel-Releasing Intrauterine System-A Review of 10 Years of Clinical Experience.

Authors:  Dirk Wildemeersch; Amaury Andrade; Norman Goldstuck
Journal:  Clin Med Insights Reprod Health       Date:  2016-08-09

10.  Intrauterine device quo vadis? Why intrauterine device use should be revisited particularly in nulliparous women?

Authors:  Dirk Wildemeersch; Norman Goldstuck; Thomas Hasskamp; Sohela Jandi; Ansgar Pett
Journal:  Open Access J Contracept       Date:  2015-01-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.